BACKGROUND: Treatment of relapsed hematological malignancies after an allogeneic
peripheral blood stem cell transplant (SCT) is challenging. Donor lymphocyte infusion (DLI) …

The main goal of post-transplantation monitoring in hematopoietic stem cell transplantation
(HSCT) is to predict negative events, such as disease relapse, graft rejection and graft …

Sequential analysis of chimerism after allogeneic blood stem cell transplantation (BSCT)
has been shown to be predictive for graft failure and relapse. We have explored the impact …

Post‐transplantation cyclophosphamide (PTC y) is an effective strategy to prevent graft‐
versus‐host disease (GVHD) after haploidentical haematopoietic cell transplantation (HCT) …

In this prospective study we analyzed pre-emptive donor leukocyte infusions (DLI) in 82
consecutive patients transplanted with partially T cell-depleted grafts for acute myeloid …

Bone marrow engraftment (BME) analysis of allogeneic bone marrow transplant (allo-BMT)
patients can detect residual recipient cells that survive the conditioning regimen. The results …

Recently, we have shown that patients with acute leukaemias and myelodysplastic
syndromes (MDS), who showed increasing mixed chimaerism (MC) upon serial PCR …

OBJECTIVE: Chimerism is well-established for surveillance of acute myeloid leukemia
(AML) patients after allogeneic hematopoietic stem cell transplantation (HSCT), but …

Hematopoietic chimerism is a measure of the number of donor and recipient cells in the host
following stem cell transplantation (SCT). The type of conditioning therapy prior to SCT has a …

The monitoring of chimerism is a standard procedure to assess engraftment and
achievement of full donor lymphoid cells after reduced intensity conditioning (RIC) stem cell …